Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C VfiledCriticalLaboratorios Liomont S A De C V
Priority to MX2016001113ApriorityCriticalpatent/MX2016001113A/en
Publication of MX2016001113ApublicationCriticalpatent/MX2016001113A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present disclosure is related to a pharmaceutical composition comprising telmisartan and hydrochlorothiazide for manufacturing a medicament for the blood pressure treatment; the present invention allows the arteries to relax, resulting in the blood pressure reduction.
MX2016001113A2016-01-262016-01-26Pharmaceutical composition and process to obtain a telmisartan and hydrochlorothiazide capsule by a wet process.
MX2016001113A
(en)
Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii
A pharmaceutical composition of solifenacin in a tablet by direct compression of oral administration, for the treatment of allopathy related to the malfunction of the bladder.